Outcomes may improve with disease-modifying drugs and lifestyle change if Alzheimer's could be identified earlier.

The five-year journey Ed Mezzanotte and his wife, Lorraine, traveled before she lost her life to Alzheimer’s disease in ...

The five-year journey Ed Mezzanotte and his wife, Lorraine, traveled before she died from Alzheimer’s was marked by heartache ...

Rippl, a Seattle startup providing virtual health care for patients with dementia, announced $23 million in new funding.

Dr. Macie P. Smith's newly-released book, A Dementia Caregiver Called to Action: The Journey examines the challenges a ...

Researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in patients with Alzheimer's by an average of 30%.

Anxiety and depression are significant risk factors for AD, and conversely, AD increases the likelihood of developing these psychiatric conditions. A systematic review of 14,760 studies showed ...

Rippl, a virtual dementia care company, secured $23 million in series A funding to expand its services to patients in more ...

The Dementia Friendly movement, begun in 2015, designates municipalities, as well as individuals, that create awareness ...

Nearly 1,000 participants gathered at Innovative Field to raise awareness and funds for Alzheimer’s care, research, and ...

Walk to End Alzheimer's Orlando, locally sponsored by The Williams Family Foundation, has raised nearly $600,000 for care, ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...